Wells Fargo’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-230	Closed	–	–	7562
2022 Q2	$0	Buy	230 +190	+475%	–	﹤0.01%	7599
2022 Q1	$0	Buy	40 +15	+60%	–	﹤0.01%	7651
2021 Q4	$0	Buy	+25	New	–	﹤0.01%	7587